Bio­phar­ma's 20 high­est-paid CEOs of 2022, each bring­ing in $20M+ pay­days

Even in a down year for much of the bio­phar­ma mar­ket, 20 CEOs brought in pay pack­ages val­ued at more than $20 mil­lion, an End­points News analy­sis found.

End­points col­lect­ed da­ta on more than 350 CEO com­pen­sa­tion pack­ages, cov­er­ing a wide range of phar­ma, biotech, and life sci­ences com­pa­nies. All told, the 20 largest earn­ers made over $725 mil­lion in 2022 — an av­er­age pack­age of $36.4 mil­lion. Three brought in pay­days over $50 mil­lion, and one CEO broke the $100 mil­lion mark.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN